Skip to main content
Article thumbnail
Location of Repository

Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated Kinase-1

By Ling Zhou, Chunli Yan, Roben G Gieling, Yujiro Kida, Warren Garner, Wei Li and Yuan-Ping Han
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (1995). Abo A: A novel serine kinase activated by rac1/CDC42Hs-dependent autophosphorylation is related to PAK65 and STE20. Embo J
    2. (2002). An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression. Biochim Biophys Acta
    3. (2003). Biology of the p21-activated kinases. Annu Rev Biochem
    4. (2002). BJ: Pak1 kinase homodimers are autoinhibited in trans and dissociated upon activation by
    5. (1999). Bokoch GM: Identification of a central phosphorylation site in p21-activated kinase regulating autoinhibition and kinase activity.
    6. (2000). Bokoch GM: p21-activated kinase (PAK1) is phosphorylated and activated by 3-phosphoinositide-dependent kinase-1 (PDK1).
    7. (1995). Bokoch GM: Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1.
    8. (1995). Cerione RA: Cdc42 and PAKmediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation.
    9. (2007). DD: Regulation of matrix metalloproteinase gene expression.
    10. (2005). E: PAK and other Rho-associated kinases – effectors with surprisingly diverse mechanisms of regulation.
    11. (1993). Engler JA: Matrix metalloproteinases: a review. Crit Rev Oral Biol Med
    12. (1998). Extracellular matrix remodeling during morphogenesis.
    13. (2008). GS: The pro-inflammatory environment in recalcitrant diabetic foot wounds. Int Wound J
    14. (1994). L: A brain serine/ threonine protein kinase activated by
    15. (2000). M: p21-activated kinase 1 activates the nuclear factor kappa B (NF-kappa B)-inducing kinaseIkappa B kinases NF-kappa B pathway and proinflammatory cytokines in Helicobacter pylori infection.
    16. (1999). Matrix metalloproteinases in repair. Wound Repair Regen
    17. (2006). Matrix metalloproteinases, the pros and cons, in liver fibrosis.
    18. (1996). MH: Actions of Rho family small G proteins and p21-activated protein kinases on mitogen-activated protein kinase family members. Mol Cell Biol
    19. (2000). MH: Stimulation of NFkappa B activity by multiple signaling pathways requires PAK1.
    20. (2001). Multiple activation loop conformations and their regulatory properties in the insulin receptor's kinase domain.
    21. (2001). Phosphorylation of Pak1 by the p35/Cdk5 kinase affects neuronal morphology.
    22. (1993). Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene
    23. (1995). Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell
    24. (2007). Tsukamoto H: A Matrix Metalloproteinase-9 Activation Cascade by Hepatic Stellate Cells in Trans-differentiation in the Three-dimensional Extracellular Matrix.
    25. (2004). Tsukamoto H: Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen.
    26. (2000). Twu YC: Tumor necrosis factor-alpha-mediated protein kinases in regulation of scavenger receptor and foam cell formation on macrophage.
    27. (1993). v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines.
    28. (1994). WC: 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen.
    29. (2008). WL: Proteolytic activation of matrix metalloproteinase-9 in skin wound healing is inhibited by alpha-1-antichymotrypsin. J Invest Dermatol
    30. (2001). WL: Transforming growth factor-beta – and tumor necrosis factor-alpha – mediated induction and proteolytic activation of MMP-9 in human skin.
    31. (2002). WL: Tumor necrosis factor-alphainduced proteolytic activation of pro-matrix metalloproteinase-9 by human skin is controlled by down-regulating tissue inhibitor of metalloproteinase-1 and mediated by tissueassociated chymotrypsin-like proteinase.
    32. (1998). Yang SD: Identification of the regulatory autophosphorylation site of autophosphorylation-dependent protein kinase (auto-kinase). Evidence that auto-kinase belongs to a member of the p21-activated kinase family.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.